IL6 and SATB2 associated disorder: SAS correlates with diabetes, hypertriglyceridemia, increased interleukin-6 (IL-6), insulin resistance, fatty liver, liver fibrosis, and inflammation [5], high density lipoprotein-cholesterol (HDL-C), but not with cholesterol, triglycerides (TG), or low-density lipoprotein-C (LDL-C) [6].